prostate cancer
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients suspected of having prostate cancer due to PSA at the first visit. Patients diagnosed with high-risk prostate cancer who have no distant metastases. Patients over the age of 20 at the time of obtaining consent. Patients who can obtain written informed consent.
Exclusion criteria
Exclusion criteria: Patients who were not tested for high-risk prostate cancer or were found to have metastatic prostate cancer as a result of further testing (however, data and samples up to that point are used for preliminary analysis).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Blood / urinalysis, physical findings, tumor assessment of prostate and pelvic lymph nodes (non-contrast MRI) are performed every 3 months. | — |
Secondary
| Measure | Time frame |
|---|---|
| Evaluation of complications (international prostate symptom score IPSS (6)), quality of life after surgery (EuroQol 5 Dimension; EQ - 5D (7) and FACT - P (8)) and erectile function (International erectile function score; Evaluation of IIEF 5 (9)) every 3 months. | — |
Countries
Japan
Contacts
Saitama Medical University International Medical Center UroOncology